Refractory Epilepsy: Clinical Trials

6 trials for Refractory Epilepsy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 6
Phase 32Completed 2
Phase 11Completed 1

Follow Refractory Epilepsy: new trials by email Literature Review of Refractory Epilepsy trials Research Report on Refractory Epilepsy

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
Ketamine Hydrochloride - Drug Resistant Epilepsy, Medically Refractory Epilepsy
Phase 2CompletedMadeline Fields122022-08-262026-09-11
Evaluation of the Modified Atkins Diet in Young Children With Refractory Epilepsy
Modified Atkin Diet - Refractory Epilepsy
Phase 2 / Phase 3CompletedLady Hardinge Medical College312012-11-012019-01-15
Efficacy of a Simplified Modified Atkins Diet in Children With Refractory Epilepsy
Simplified Modified Atkins Diet, Antiepileptic drugs alone - Refractory Epilepsy
Phase 2 / Phase 3CompletedLady Hardinge Medical College812012-09-012019-01-15
A Controlled Clinical Trial of Cathodal Transcranial Direct Current Stimulation in Patients With Refractory Epilepsy
Nicolet Endeavor CR: 30min, Nicolet Endeavor CR: 60min, Nicolet Endeavor CR: 30min for 3 days - Refractory Epilepsy
Phase 2CompletedEl Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez282012-02-012015-04-07
Thalidomide Low Threshold in Epilepsy
3-phthalimidoglutarimide (Thalidomide) - Refractory Epilepsy
Phase 1 / Phase 2CompletedNational Institute of Neurology and Neurosurgery, Mexico72006-06-012010-02-18
Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy
RWJ-333369 - Refractory Epilepsy
Phase 2CompletedSK Life Science, Inc.2005-02-012012-08-02

Narrower conditions

Drug Resistant Epilepsy (6)  ·  Seizures (1)

Broader conditions

Brain Diseases (6)  ·  Central Nervous System Diseases (6)  ·  Epilepsy (6)  ·  Nervous System Diseases (6)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Anticonvulsants (1)  ·  Ketamine (1)  ·  S-2-O-carbamoyl-1-o-chlorophenyl-ethanol (1)  ·  Thalidomide (1)  ·  Transcranial Direct Current Stimulation (1)

Sponsors

Lady Hardinge Medical College (2)  ·  El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez (1)  ·  Madeline Fields (1)  ·  National Institute of Neurology and Neurosurgery, Mexico (1)  ·  SK Life Science, Inc. (1)

Countries

India (2)  ·  United States (2)  ·  Argentina (1)  ·  Hungary (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Russia (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Satinder Aneja, MD (2)  ·  Daniel San-juan, MD (1)  ·  Julio Sotelo, MD (1)  ·  Lara Marcuse, MD (1)  ·  Madeline Fields, MD (1)

Results publications

PMID 16499758, PMID 21167786, PMID 27693237, PMID 32588435, PMID 34870321